Company page

Oxford Biomedica Plc

Oxford Biomedica Plc is a public company listed on the UK market under the ticker OXB, with a market capitalization of approximately £940.87 million. The company specializes in gene and cell therapy, focusing on developing innovative treatments for various diseases. Oxford Biomedica is known for its advanced manufacturing capabilities and collaborations with leading pharmaceutical companies.

OXB:LSEUpdated August 28, 2026
Oxford Biomedica Plc logo
Ticker
OXB:LSE
Asset type
Stock
Market cap
$866.8M
Sector
Health Technology
Industry
Biotechnology
Exchange
LSE
Currency
GBX